User Posts: admin3
0
A Poem About Finding Purpose and Looking Ahead During Cancer
0

A melanoma survivor, Ohara found a purpose to keep her going. LossI lost something the other day,I didn’t just drop it,It was taken from meAnd where it ...

0
Tesco reach £70m milestone for Cancer Research UK – Cancer Research UK
0

Tesco have raised an incredible £70m to fund life saving cancer research. We’re so grateful for the support and are privileged to have been in ...

0
My Hereditary Breast Cancer Story
0

I don’t have the BRCA gene mutation. Neither does my daughter. She and I are the third and fourth generations of women on the maternal side of our ...

0
Opdivo Before and After Surgery Improves Event-Free Survival in NSCLC
0

Patients with stage 3 N2 and stage 3 non-N2 non-small cell lung cancer (NSCLC) treated with presurgical Opdivo (nivolumab) plus chemotherapy, followed by ...

0
Long-Term Postsurgical ADT May Reduce Prostate Cancer Metastasis Risk
0

Patients who received ADT for two years were less likely to develop metastatic disease, an expert told CURE®.The addition of two years of androgen ...

0
First ever winner in our Research is Beautiful campaign – Cancer Research UK
0

To enter, e-mail your photos to  with a short caption and your contact details. Images should be sent as JPEG files and, ideally, be at least 2000px. Feel ...

0
Dato-DXd Improves Antitumor Intracranial Responses in NSCLC Subgroups
0

Patients with advanced or metastatic non-small cell lung cancer (NSCLC) who were previously treated demonstrated promising antitumor intracranial (within ...

0
Vaccine-Based Combo Shows Disease Control in CRC
0

The PolyPEPI1018 vaccine, when given with the immunotherapy drug, Tecentriq (atezolizumab), induced immune responses against tumors in a small group of ...

0
How can we share research together? Insights from a graphic designer – Cancer Research UK
0

As it had been agreed to keep the information sheet to two pages of A4 (or one A3-sized spread), space was at a premium and every word of text was ...

0
Bile Duct Cancer Continues to Respond to Zanidatamab, Per Longer Follow-Up
0

Zanidatamab continued to be efficacious in treating patients with previously treated advanced, unresectable, or metastatic HER2-amplified biliary tract ...

User Deals: admin3
Browsing All Comments By: admin3
CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart